RAPT Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell RAPT and other ETFs, options, and stocks.About RAPT
Rapt Therapeutics, Inc. operates as a clinical stage immunology-based biopharmaceutical company, which engages in the discovery, development, and commercialization of oral small molecule therapies for patients in oncology and inflammatory diseases. The company was founded in 2015 and is headquartered in South San Francisco, CA.
CEOBrian Russell Wong
CEOBrian Russell Wong
Employees68
Employees68
HeadquartersSouth San Francisco, California
HeadquartersSouth San Francisco, California
Founded2015
Founded2015
Employees68
Employees68
RAPT Key Statistics
Market cap955.19M
Market cap955.19M
Price-Earnings ratio-3.11
Price-Earnings ratio-3.11
Dividend yield—
Dividend yield—
Average volume432.17K
Average volume432.17K
High today$34.73
High today$34.73
Low today$31.72
Low today$31.72
Open price$32.08
Open price$32.08
Volume438.73K
Volume438.73K
52 Week high$42.39
52 Week high$42.39
52 Week low$5.67
52 Week low$5.67
Stock Snapshot
The current RAPT Therapeutics(RAPT) stock price is $34.47, with a market capitalization of 955.19M. The stock trades at a price-to-earnings (P/E) ratio of -3.11.
On 2025-12-05, RAPT Therapeutics(RAPT) stock traded between a low of $31.72 and a high of $34.73. Shares are currently priced at $34.47, which is +8.7% above the low and -0.7% below the high.
The RAPT Therapeutics(RAPT)'s current trading volume is 438.73K, compared to an average daily volume of 432.17K.
In the last year, RAPT Therapeutics(RAPT) shares hit a 52-week high of $42.39 and a 52-week low of $5.67.
In the last year, RAPT Therapeutics(RAPT) shares hit a 52-week high of $42.39 and a 52-week low of $5.67.
Analyst ratings
90%
of 10 ratingsBuy
90%
Hold
10%
Sell
0%
People also own
Based on the portfolios of people who own RAPT. This list is generated using Robinhood data, and it’s not a recommendation.